Benzinga's Top Upgrades, Downgrades For May 21, 2019

Loading...
Loading...

Top Upgrades

  • BMO Capital upgraded Polaris Industries Inc. PII from Market Perform to Outperform. Polaris shares rose 4.6 percent to $89.89 in pre-market trading.
  • Analysts at Bernstein upgraded Kroger Co KR from Market Perform to Outperform. Kroger rose 1.5 percent to $24.42 in pre-market trading.
  • Analysts at Canaccord Genuity upgraded Just Energy Group Inc JE from Hold to Speculative Buy. Just Energy shares rose 1.3 percent to $3.25 in pre-market trading.
  • Guggenheim upgraded Tripadvisor Inc TRIP from Sell to Neutral. TripAdvisor shares rose 1.9 percent to $45.80 in pre-market trading.
  • Bank of America upgraded Deckers Outdoor Corp DECK from Neutral to Buy. Deckers Outdoor shares rose 0.1 percent to close at $142.74 on Monday.
  • Zelman upgraded Stanley Black & Decker, Inc. SWK from Hold to Buy. Stanley Black & Decker rose 0.2 percent to close at $135.12 on Monday.
  • Credit Suisse upgraded Apollo Global Management LLC APO from Neutral to Outperform. Apollo Global shares fell 0.6 percent to close at $32.13 on Monday.
  • Analysts at UBS upgraded S&P Global Inc SPGI from Neutral to Buy. S&P Global shares fell 0.5 percent to close at $211.83 on Monday.
  • Raymond James upgraded Amneal Pharmaceuticals Inc AMRX from Market Perform to Strong Buy. Amneal Pharmaceuticals rose 5.1 percent to $8.68 in pre-market trading.

 

Top Downgrades

  • Desjardins downgraded Cae Inc CAE from Buy to Hold. CAE shares fell 0.4 percent to $26.57 in pre-market trading.
  • RBC Capital downgraded Gran Tierra Energy Inc GTE from Top Pick to Outperform. Gran Tierra Energy shares closed at $2.14 on Monday.
  • Raymond James downgraded Ocular Therapeutix Inc OCUL from Strong Buy to Outperform. Ocular Therapeutix shares fell 15.7 percent to $2.84 in pre-market trading.
  • Credit Suisse downgraded The Carlyle Group LP CG from Outperform to Neutral. Carlyle shares fell 0.8 percent to close at $20.76 on Monday.
  • Credit Suisse downgraded KKR & Co Inc KKR from Outperform to Neutral. KKR shares fell 0.7 percent to close at $24.50 on Monday.
  • UBS downgraded Tremont Mortgage Trust TRMT from Buy to Neutral. Tremont Mortgage Trust rose 0.4 percent to close at $5.17 on Monday.

 

Top Initiations

  • Analysts at Credit Suisse initiated coverage on Amgen, Inc. AMGN with an Outperform rating. The price target for Amgen is set to $208. Amgen shares closed at $168.39 on Monday.
  • Consumer Edge Research initiated coverage on Uber Technologies Inc UBER with an Equal-Weight rating. Uber shares closed at $41.59 on Monday.
  • Deutsche Bank initiated coverage on Target Hospitality Corp TH with a Buy rating. The price target for Target Hospitality is set to $14. Target Hospitality shares closed at $10.83 on Monday.
  • Analysts at Credit Suisse initiated coverage on Incyte Corporation INCY with a Neutral rating. The price target for Incyte is set to $75. Incyte shares closed at $76.83 on Monday.
  • Canaccord Genuity initiated coverage on X4 Pharmaceuticals Inc XFOR with a Buy rating. The price target for X4 Pharmaceuticals is set to $27. X4 Pharmaceuticals closed at $16.96 on Monday.
  • H.C. Wainwright initiated coverage on Aeglea Bio Therapeutics Inc AGRX with a Buy rating. The price target for Aeglea Bio Therapeutics is set to $20. Aeglea Bio Therapeutics shares closed at $6.50 on Monday.
  • Analysts at DA Davidson initiated coverage on Hillenbrand, Inc. HI with a Neutral rating. The price target for Hillenbrand is set to $43. Hillenbrand closed at $38.96 on Monday.
  • Empire Asset Management initiated coverage on Evolus Inc EOLS with a Sell rating. The price target for Evolus is set to $6. Evolus closed at $17.38 on Monday.
  • Credit Suisse initiated coverage on Biogen Inc BIIB with an Underperform rating. The price target for Biogen is set to $198. Biogen shares closed at $230.76 on Monday.
  • Analysts at Credit Suisse initiated coverage on Vertex Pharmaceuticals Incorporated VRTX with an Outperform rating. The price target for Vertex Pharmaceuticals is set to $209. Vertex Pharmaceuticals shares closed at $165.73 on Monday.
Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsInitiationstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...